BChE-IN-35
BChE-IN-35 (Azo-9) is a BChE inhibitor. BChE-IN-35 has a dynamic cis/trans conformational change, where the cis isomer preferentially binds to BChE. BChE-IN-35 can be used in Alzheimer's disease (AD) research[1].
Product Specifications
UNSPSC
12352005
Target
Cholinesterase (ChE)
Type
Reference compound
Related Pathways
Neuronal Signaling
Field of Research
Neurological Disease
Assay Protocol
https://www.medchemexpress.com/bche-in-35.html
Smiles
CC(C)C1=CC=C(/N=N\C2=CC=C(C(NC3=CC=CC(C(NCC4=CC=CC=C4CN(CC)CC)=O)=C3)=O)C=C2)C=C1
Molecular Formula
C35H39N5O2
Molecular Weight
561.72
References & Citations
[1]Wang L, et al. Optical control of butyrylcholinesterase (BChE) activity via photoswitchable azobenzene for potential treatment of Alzheimer's disease. Bioorg Chem. 2024 Sep 24;153:107845.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
BChE
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
PKSV030463 100 µg
Recombinant SARS-CoV-2 Spike RBD (F486S) (His Tag)
Sign In for Pricing
View Details 
![PE Anti-Human CD180 Antibody[MHR73-11]](https://cdn.genprice.uk/products/763/68dd14ad061270361e7d3434/imageurl08/an00326d.webp)